Dashboard
Manage Tickers

BNTXBioNTech SE

Nasdaq biontech.de


$ 127.72 $ 5.73 (4.7 %)    

Monday, 16-Sep-2024 12:09:38 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 471.45 $ -1.61 (-0.34 %)
DIA $ 415.96 $ -0.99 (-0.24 %)
SPY $ 561.04 $ -0.43 (-0.08 %)
TLT $ 101.06 $ 0.43 (0.43 %)
GLD $ 238.41 $ -0.19 (-0.08 %)
$ 123.4
$ 121.99
$ 115.06 x 800
$ 127.85 x 100
$ 121.00 - $ 129.20
$ 76.53 - $ 125.41
6,298,034
na
29.34M
$ 0.07
$ 0.03
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

desantis-administration-cautions-against-pfizer-moderna-mrna-covid-vaccines-for-vulnerable-individuals-cites-concerns-related-to-rare-heart-conditions
DeSantis Administration Cautions Against P...
09/16/2024 15:18:10

Florida advises against mRNA Covid vaccines for vulnerable residents, citing safety concerns. Gov. DeSantis' administration...

jp-morgan-upgrades-biontech-to-neutral-raises-price-target-to-125
JP Morgan Upgrades BioNTech to Neutral, Ra...
09/16/2024 13:16:43

JP Morgan analyst Jessica Fye upgrades BioNTech (NASDAQ:BNTX) from Underweight to Neutral and raises the price target from $...

b-of-a-securities-maintains-buy-on-biontech-raises-price-target-to-150
B of A Securities Maintains Buy on BioNTec...
09/16/2024 12:13:49

B of A Securities analyst Tazeen Ahmad maintains BioNTech (NASDAQ:BNTX) with a Buy and raises the price target from $125 to ...

hc-wainwright--co-reiterates-buy-on-biontech-maintains-113-price-target
HC Wainwright & Co. Reiterates Buy on BioN...
09/16/2024 11:30:13

HC Wainwright & Co. analyst Robert Burns reiterates BioNTech (NASDAQ:BNTX) with a Buy and maintains $113 price target.

Core News & Articles
Chewy, Broadcom And MicroStrategy Are Amon...
09/15/2024 15:48:51

These ten stocks saw significant gains last week, with Summit Therapeutics up 98.32% and BioNTech up 31.77%. Analysts also rais...

forecasting-the-future-8-analyst-projections-for-biontech
Forecasting The Future: 8 Analyst Projecti...
09/13/2024 20:02:46

jefferies-maintains-hold-on-biontech-raises-price-target-to-96
Jefferies Maintains Hold on BioNTech, Rais...
09/13/2024 18:23:25

Jefferies analyst Akash Tewari maintains BioNTech (NASDAQ:BNTX) with a Hold and raises the price target from $90 to $96.

Core News & Articles
"Florida Discourages Use Of mRNA Covid Vac...
09/13/2024 17:21:41

https://www.nbcnews.com/health/health-news/florida-covid-shots-mrna-vaccines-older-adults-rcna170997Even as the Covid wave in F...

market-whales-and-their-recent-bets-on-bntx-options
Market Whales and Their Recent Bets on BNT...
09/13/2024 14:04:48

gsk-halts-herpes-simplex-virus-vaccine-development-clears-path-for-other-contenders-like-moderna-biontech
GSK Halts Herpes Simplex Virus Vaccine Dev...
09/11/2024 16:13:09

GSK Plc has halted development of its herpes simplex virus vaccine, GSK3943104, after it failed to meet efficacy goals in clini...

why-is-moderna-stock-trading-higher-on-monday
Why Is Moderna Stock Trading Higher On Mon...
09/09/2024 17:00:47

Moderna's Laval, Quebec, facility received a Drug Establishment License from Health Canada, allowing it to produce mRNA vac...

modernas-investigational-mpox-vaccine-more-effective-than-current-approved-shot-animal-study-shows
Moderna's Investigational Mpox Vaccine Mor...
09/06/2024 18:02:39

Moderna is conducting a Phase 1/2 trial of mRNA-1769, a potential mpox vaccine for adults. Early research shows it may outperfo...

biontech-to-present-clinical-trial-data-for-selected-assets-from-its-multi-platform-oncology-pipeline-at-the-european-society-for-molecular-oncology-congress-2024-spain
BioNTech To Present Clinical Trial Data Fo...
09/05/2024 11:21:15

Core News & Articles
Tempus Announces Real World Data Collabora...
09/04/2024 12:33:33

The strategic collaboration will leverage Tempus' large multimodal datasets to enhance BioNTech's next-generation oncol...

uk-taiwan-approve-modernas-updated-covid-19-shot
UK, Taiwan Approve Moderna's Updated COVID...
09/03/2024 18:39:51

The Medicines and Healthcare Products Regulatory Agency has approved Moderna's updated COVID-19 vaccine targeting the JN.1 ...

Core News & Articles
Moderna And BioNTech Bet On Personalized C...
08/29/2024 16:01:34

BioNTech and Moderna are advancing personalized cancer vaccines using mRNA technology. Despite promising early results, these i...

hc-wainwright--co-reiterates-buy-on-biontech-maintains-113-price-target
HC Wainwright & Co. Reiterates Buy on BioN...
08/27/2024 10:35:46

HC Wainwright & Co. analyst Robert Burns reiterates BioNTech (NASDAQ:BNTX) with a Buy and maintains $113 price target.

americans-to-access-covid-19-test-kits-for-free-as-us-government-restarts-free-at-home-program
Americans To Access COVID-19 Test Kits For...
08/26/2024 15:24:26

US households can order free COVID-19 tests starting in late September as the government reopens the program ahead of the fall ...

Core News & Articles
U.S. CDC Says For This Season Peak Hospita...
08/23/2024 15:51:38

- Press Conference

fda-approves-updated-covid-vaccines-from-pfizer-and-moderna-but-leaves-out-novavaxs-shot
FDA Approves Updated COVID Vaccines From P...
08/22/2024 18:33:49

The FDA granted emergency use authorization for updated mRNA COVID-19 vaccines targeting the Omicron KP.2 strain, including new...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION